Scientist (3rd party), Biomarker Research
职位描述
职位描述:
DESCRIPTION
The successful candidate will join a multidisciplinary research team focusing on drug discovery, translational research, and early development of novel small or large molecule drug candidates in Shanghai, China. This person is expected to take responsibilities in immunohistochemistry (IHC) assay development and execution, to provide histo-pathology support to biomarker research and joint projects with drug discovery, translational research, and early development teams. The successful candidate should have a well-established track record in Bio-medical research, ideally working experience in pathology platform of pharmaceutical R&D or CRO. Good communication skills in both English and Chinese, as well as an ability to interact with collaboration partners both internally and externally.
TECHNICAL SKILLS, EXPERIENCE & KNOWLEDGE:
A thorough understanding of immunohistochemistry and histo-pathology
An ability to independently generate precise, reliable data and skillfully analyze and interpret it
Hands-on experience in preparation, fixation, embedding, sectioning of FFPE samples, and IHC assay execution, data capture is a must
Hands-on experience in developing, validating and executing common oncology/immunology biomarker IHC assays independently is an advantage
Experience with pathological quantitation and scoring is a strong plus
Experience with fluorescent staining, FISH, ViewRNA on clinical samples is a strong plus
KEY RESPONSIBILITIES
Routine characterization of cellular, pre-clinical, clinical samples with established biomarker assays, eg. IHC, WB etc.
Develop, optimize, validate, trouble shoot and execute IHC and other histo-pathology assays
Integrate appropriate automated devices to improve assay throughput and robustness
The successful candidate is expected to analyze, interpret and report experimental results independently
The successful candidate may be actively engaged in participating and evaluating progress in collaborative programs with external partners. Experience in collaborative research would be desirable
EDUCATION, EXPERIENCE, QUALIFICATIONS
The candidate should have a Master/PhD/MD degree in medicine, biology, pathology or a related field, preferably experience in pre-clinical drug discovery or translational research in a pharmaceutical setting or other relevant healthcare industry.
A thorough understanding and experience in cancer biology is a plus.
Hands on experience with cutting edge cellular and molecular technologies related to Oncology biomarker research would be a clear advantage.
Demonstrated ability to work in a team oriented environment.
Good written and oral communication skill in both English and Chinese
企业简介
美国强生公司创建于1886年,目前在全球60个国家建立了250多家分公司,是目前世界上最具综合性、业务分布范围最广的卫生保健产品的制造商和相关服务提供商,业务领域主要包括制药,医疗器械和消费品。
西安杨森制药有限公司是美国强生公司在华最大的子公司,成立于1985年。公司管理中心在北京,生产基地位于西安,在全国28个城市设有办事处,在华员工超过3000人。在过去的25年中,西安杨森保持持续稳定发展,成为了中国领先的合资制药企业。
西安杨森不断引进和生产多种创新的、高品质的药品,其产品包括多种高质量的处方药,以及广受患者信赖的非处方药物。西安杨森依托强生公司全球强大的研究开发体系,着眼于未来,不断引进新的药品,计划上市生物制剂、肿瘤、心血管、风湿和泌尿等更多领域的产品以服务于中国的广大患者。
西安杨森公司遵从强生信条的原则,致力于公司的长期发展。这是公司在过去取得成功的基石,也是未来成长的保障。
西安杨森公司获得众多奖项和赞誉,比如《财富》杂志评选的“中国最受赞赏的外资企业”及“人力资源经理眼中的热门雇主”;中国中央电视台 “2005CCTV中国年度雇主”;CRF评选的2007-2008年度北京地区“中国杰出雇主”;2008年与强生在华公司一起荣获“第六届中国大学生最佳雇主奖和进步飞速奖”称号,和2009年“第七届中国大学生最佳雇主奖”,并位列医药行业第一名。2010年强生在华公司荣获“第八届中国大学生最佳雇主制药/医疗行业最佳雇主第一名”。这是继上届强生公司获得医药行业第一名后再次蝉联这项荣誉。
热门区域招聘: 重庆 北京 上海 浙江 江苏 广东 山东 湖南 安徽 河北
上海招聘企业: 百进冠合(海南) 医疗科技有限公司 上海华茂药业有限公司 上海信谊药厂有限公司 上海强生制药 欧姆龙健康医疗(中国)有限公司 青海瑞成药业(集团)有限公司 上海交通大学医学院附属瑞金医院 复旦大学附属中山医院 上海复星医药 上海医药集团
职位发布日期: 2016-11-23